Interim analyses {21b}

SL Shuang Liu
JL Jin-Tao Liu
LC Lin Chen
TF Tian-You Fan
XC Xue-Jun Cui
SC Shao-Dan Cheng
YC Yan-Jiao Chen
QS Qi Shi
CX Chun-Chun Xue
XL Xiao-Feng Li
ask Ask a question
Favorite

N/A. On the basis of previous observation and clinical practice experience, we judge that there will be no high-grade adverse events during the study; therefore, we have not set an interim analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A